Filing Details
- Accession Number:
- 0001209191-23-058111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-11 18:00:08
- Reporting Period:
- 2023-12-07
- Accepted Time:
- 2023-12-11 18:00:08
- SEC Url:
- Form 4 Filing
Issuer
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1673243 | Shyam Kambeyanda | 909 Rose Avenue, Suite 800 North Bethesda MD 20852 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $.001 | Acquisiton | 2023-12-07 | 33,800 | $50.43 | 78,274 | No | 4 | M | Direct | |
| Common Stock, Par Value $.001 | Disposition | 2023-12-07 | 27,098 | $81.81 | 51,176 | No | 4 | F | Direct | |
| Common Stock, Par Value $.001 | Disposition | 2023-12-08 | 6,702 | $81.07 | 44,474 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 | Employee Stock Option (right to buy) | Disposition | 2023-12-07 | 33,800 | $0.00 | 33,800 | $50.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-04-05 | 2024-02-12 | No | 4 | M | Direct |
Footnotes
- Represents shares withheld by ESAB Corporation in connection with net share settlement to satisfy the tax liability and exercise price associated with the reporting person's exercise of employee stock options. No shares were sold by the reporting person to satisfy the exercise price or this tax liability.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
Billionaire Hedge Funds
